Centre of Excellence for Long-acting Therapeutics

The Centre of Excellence in Long-acting Therapeutics (CELT) is a cross-faculty research initiative combining our world leading expertise in pharmacology and materials chemistry and working with international partners to disseminate research findings in long-acting medicine and change the global landscape of drug administration.

Long-acting therapeutics can have a huge impact for treatment and prevention of chronic diseases but also other applications for acute diseases where multiple pharmaceutical doses are required for successful therapy. We intend to implement impactful solutions to the critical challenges that affect those suffering from these diseases and work with partners to better understand how these technologies can be of most benefit.

CELT aims to provide a better understanding for a range of technologies, to develop new interventions and harmonise strategies to accelerate long-acting therapeutic development and implementation. We are collaborating globally with industrial, academic and charitable partners as well as patients and doctors, and are keen to establish new links to programmes that aim to deliver clear patient benefits.

Keep up to date with all CELT news and developments by subscribing to our mailing list.


The Centre of Excellence for Long-acting Therapeutics has been established with funding from Unitaid.

Back to: Centre of Excellence for Long-acting Therapeutics